Initiator Pharma A/S (INIT.ST)

SEK 6.36

(1.92%)

Long Term Debt Summary of Initiator Pharma A/S

  • Initiator Pharma A/S's latest annual long term debt in 2023 was 15.43 Million DKK , up 22.74% from previous year.
  • Initiator Pharma A/S's latest quarterly long term debt in 2024 Q2 was - DKK , down 0.0% from previous quarter.
  • Initiator Pharma A/S reported annual long term debt of 12.57 Million DKK in 2022, down -5.36% from previous year.
  • Initiator Pharma A/S reported annual long term debt of 13.29 Million DKK in 2021, down 0.0% from previous year.
  • Initiator Pharma A/S reported quarterly long term debt of - DKK for 2024 Q2, down 0.0% from previous quarter.
  • Initiator Pharma A/S reported quarterly long term debt of 12.7 Million DKK for 2023 Q1, up 1.04% from previous quarter.

Annual Long Term Debt Chart of Initiator Pharma A/S (2023 - 2016)

Historical Annual Long Term Debt of Initiator Pharma A/S (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 15.43 Million DKK 22.74%
2022 12.57 Million DKK -5.36%
2021 13.29 Million DKK 0.0%
2020 - DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK 0.0%

Peer Long Term Debt Comparison of Initiator Pharma A/S

Name Long Term Debt Long Term Debt Difference
Lipum AB (publ) 1.76 Million SEK -776.604%
Alligator Bioscience AB (publ) 7.51 Million SEK -105.389%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK -617.333%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -1716.118%
Genovis AB (publ.) 74.8 Million SEK 79.365%
CombiGene AB (publ) - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -10771.127%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK -414.567%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 52.621%
Ziccum AB (publ) 286 Thousand SEK -5297.552%
Camurus AB (publ) 13.61 Million SEK -13.399%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 37.02%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 51.679%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 76.337%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK -259.334%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 86.326%
Abliva AB (publ) 424 Thousand SEK -3540.802%
Corline Biomedical AB - SEK -Infinity%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 85.071%
Asarina Pharma AB (publ) 1 Million SEK -1443.7%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 98.357%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 98.173%
Cyxone AB (publ) 74 Thousand SEK -20760.811%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -975.0%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -11250.735%
SynAct Pharma AB 58 Thousand SEK -26515.517%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK -6.206%
Diagonal Bio AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -1716.118%
Alzinova AB (publ) 800 Thousand SEK -1829.625%
Ascelia Pharma AB (publ) 176 Thousand SEK -8671.023%
Oncopeptides AB (publ) 106.48 Million SEK 85.503%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 82.988%
Diamyd Medical AB (publ) 30.67 Million SEK 49.671%